ImmunoPrecise Antibodies (IPA) News Today $2.10 +0.17 (+8.55%) Closing price 09/3/2025 07:52 PM EasternExtended Trading$2.10 0.00 (0.00%) As of 09/3/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IPA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT”September 3 at 8:48 AM | businesswire.comImmunoPrecise Antibodies to Participate at H.C. Wainwright's 27th Annual Global Investment Conference in New YorkSeptember 2, 2025 | uk.finance.yahoo.comImmunoPrecise Antibodies (NASDAQ:IPA) Stock Price Down 0.4% - What's Next?August 29, 2025 | marketbeat.comImmunoPrecise Advances AI Discovered and Developed Universal Dengue Vaccine Initiative: Moves into Preclinical Antibody GenerationAugust 27, 2025 | businesswire.comImmunoprecise Antibodies Ltd News (IPA) - Investing.comAugust 24, 2025 | investing.comShort Interest in ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Grows By 46.3%August 21, 2025 | marketbeat.comImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate ...August 6, 2025 | gurufocus.comImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate ...August 6, 2025 | gurufocus.comImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio-Native AI InnovationAugust 6, 2025 | financialpost.comFShort Interest in ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Expands By 114.5%August 6, 2025 | marketbeat.comImmunoPrecise (IPA) Q4 2025 Earnings TranscriptAugust 4, 2025 | fool.comHC Wainwright Has Positive Outlook for IPA FY2028 EarningsAugust 4, 2025 | marketbeat.comWall Street Zen Upgrades ImmunoPrecise Antibodies (NASDAQ:IPA) to "Hold"August 3, 2025 | marketbeat.comHC Wainwright Has Negative Outlook of IPA Q1 EarningsAugust 2, 2025 | marketbeat.comImmunoPrecise Antibodies (NASDAQ:IPA) Issues Earnings ResultsJuly 30, 2025 | marketbeat.comIPA interactive stock chart | ImmunoPrecise Antibodies Ltd. stock - Yahoo FinanceJuly 29, 2025 | nz.finance.yahoo.comImmunoPrecise Antibodies Reports Record Revenue and GrowthJuly 29, 2025 | tipranks.comImmunoPrecise Antibodies Reports Record Fiscal Year 2025 ResultsJuly 29, 2025 | tipranks.comImmunoPrecise Antibodies (IPA) Reports Full Fiscal Year 2025 Results, Record Fourth Quarter Revenue, and Record Fourth Quarter Adjusted EBITDAJuly 29, 2025 | businesswire.comImmunoPrecise Unveils Breakthrough in Predicting Drug Antibody RisksJuly 24, 2025 | tipranks.comImmunoPrecise Releases New Findings Showing LENSai™ Quickly Flags Anti-Drug-Antibody Risk—Long Before the ClinicJuly 24, 2025 | businesswire.comImmunoPrecise Antibodies (IPA) Projected to Post Earnings on TuesdayJuly 22, 2025 | marketbeat.comImmunoPrecise Antibodies (NASDAQ:IPA) Shares Up 6% - Should You Buy?July 17, 2025 | marketbeat.comIPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2025 on July 29, 2025July 16, 2025 | businesswire.comImmunoPrecise Regains Compliance with Nasdaq Minimum Bid Price RequirementJuly 14, 2025 | financialpost.comFImmunoPrecise Regains Compliance with Nasdaq Minimum Bid Price RequirementJuly 14, 2025 | financialpost.comFImmunoPrecise Regains Compliance with Nasdaq Minimum Bid Price RequirementJuly 14, 2025 | businesswire.comImmunoPrecise Antibodies Appoints Industry Veteran Jon Lieber to Board of Directors - MorningstarJuly 8, 2025 | morningstar.comMImmunoPrecise Antibodies Strengthens Board with Industry Veteran Jon LieberJuly 7, 2025 | tipranks.comImmunoPrecise Validates LENSai Epitope Mapping Platform Across Broad Range of Unseen Therapeutic Targets Beyond Training DataJuly 3, 2025 | businesswire.comImmunoPrecise Advances Universal Dengue Vaccine, Confirming Safety, Immune Activation, and Structural Stability Using its LENSai™ Platform Powered by Patented HYFT® TechnologyJune 24, 2025 | businesswire.comWe're Keeping An Eye On ImmunoPrecise Antibodies' (NASDAQ:IPA) Cash Burn RateJune 18, 2025 | finance.yahoo.comAI-Designed GLP-1 Peptides from ImmunoPrecise Antibodies Surpass Semaglutide in Receptor Activation StudiesJune 12, 2025 | financialpost.comFAI-Designed GLP-1 Peptides from ImmunoPrecise Antibodies Surpass Semaglutide in Receptor Activation StudiesJune 12, 2025 | businesswire.comImmunoPrecise Announces AI-Driven Breakthrough in Universal Dengue Vaccine DiscoveryJune 5, 2025 | businesswire.comImmunoPrecise Antibodies Engages CORE IR to Enhance Investor Engagement EffortsMay 21, 2025 | businesswire.comImmunoPrecise Antibodies (IPA) to Present at Maxim Group’s 2025 Virtual Tech ConferenceMay 20, 2025 | uk.finance.yahoo.comImmunoPrecise Antibodies to Present at Maxim Group’s 2025 Virtual Tech ConferenceMay 20, 2025 | tipranks.comImmunoPrecise Antibodies (IPA) to Present at Maxim Group's 2025 Virtual Tech ConferenceMay 20, 2025 | businesswire.comIPA’s LENSai™ Platform Delivers X-Ray–Level Epitope Mapping Insights in Hours, Matching Gold-Standard Methods with Greater SpeedMay 12, 2025 | finance.yahoo.comIPA's LENSai™ Platform Delivers X-Ray–Level Epitope Mapping Insights in Hours, Matching Gold-Standard Methods with Greater SpeedMay 12, 2025 | businesswire.comCarterra Announces its 2025 Symposia Series on Speeding Drug Discovery with AI/ML and Other New TechnologiesApril 24, 2025 | finance.yahoo.comImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA's Shift to Non-Animal Testing MethodsApril 11, 2025 | uk.finance.yahoo.comImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA’s Shift to Non-Animal Testing MethodsApril 11, 2025 | financialpost.comFImmunoPrecise Antibodies Partners with RIBOPRO to Enhance Antibody DiscoveryApril 10, 2025 | tipranks.comImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2025 Earnings Call TranscriptApril 1, 2025 | msn.comImmunoPrecise Antibodies reports Q3 EPS (C$0.66) vs. (C$0.10) last yearMarch 29, 2025 | markets.businessinsider.comIMMUNOPRECISE ANTIBODIES Earnings Preview: Recent $IPA Insider Trading, Hedge Fund Activity, and MoreMarch 28, 2025 | nasdaq.comImmunoPrecise Antibodies Ltd. (IPA) Q3 2025 Earnings Call TranscriptMarch 28, 2025 | seekingalpha.comImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025March 28, 2025 | businesswire.com Get ImmunoPrecise Antibodies News Delivered to You Automatically Sign up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IPA Media Mentions By Week IPA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IPA News Sentiment▼0.330.71▲Average Medical News Sentiment IPA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IPA Articles This Week▼31▲IPA Articles Average Week Get the Latest News and Ratings for IPA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for ImmunoPrecise Antibodies and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Prime Medicine News Canopy Growth News Nanobiotix News Corvus Pharmaceuticals News Solid Biosciences News COMPASS Pathways News Upexi News Replimune Group News PureTech Health News Inhibrx Biosciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IPA) was last updated on 9/6/2025 by MarketBeat.com Staff From Our PartnersThe Altcoin That Could be Poised to Benefit Most from Trump’s ReturnWith Trump back in office, the crypto tide is turning fast. Regulation is easing. Momentum is building. And ac...Weiss Ratings | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWarren Buffett's Strangest AI InvestmentTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredOdd trade could help investors secure their wealth in 2025The most profitable phrase you’ve never heard of... Have you heard of 310F? This simple string of code coul...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunoPrecise Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
